ArticleCells2023

XPF-ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer.

Ming-Yii Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.